19-year-old experiencing hairloss seeks advice on treatments. Suggestions include Finasteride, Minoxidil, microneedling, hair systems, and consulting a dermatologist.
Topical Dutasteride may halt hairloss and effectively treat androgenic alopecia. Combining low-dose oral Dutasteride with topical application could maximize regrowth and minimize side effects.
A new hairloss treatment theory beyond minoxidil and finasteride is proposed, causing mixed reactions in the community, with some members eager to explore and support it, while others call for more research and evidence.
Treatments for hairloss, such as Minoxidil, finasteride, RU58841 and Eucapil; the legitimacy of RU58841 products; and safety concerns related to using RU58841.
A user started taking finasteride 1mg/day for hairloss but hasn't seen results yet. They also take vitamins and asked about adding minoxidil and the effectiveness of LLLT.
The conversation discusses the hairloss treatment Breezula by Cassiopea, which had a successful Phase II trial and is expected to start Phase III by the end of the year. Users are curious about the timeline for availability and note that it performs slightly better than finasteride at 6 months, slightly worse at 12 months, with the benefit of having no side effects.
The conversation discusses treating side effects of hairloss treatments. Recommendations include lifting heavy weights, reducing body fat, taking ZMA and D3 supplements, improving diet, taking DIM, reducing finasteride dosage, avoiding alcohol, drinking water, getting quality sleep, and not obsessing over side effects.
People worrying about hairloss and the effects of Finasteride on erections, which a transgirl has experienced no change from taking it with other medications. The discussion suggests that people should stop worrying so much.
A person experienced hairloss due to a crash diet and is now seeking advice on recovery, including dietary changes and potential treatments like biotin and pumpkin seed oil. They are concerned about nutrient deficiencies and considering a dermatologist visit for further guidance.
Finasteride and minoxidil stopped hairloss and improved urinary issues for a 34-year-old user. Despite some sexual side effects, the user plans to continue finasteride, while considering restarting minoxidil.
Many delay hairloss treatment due to lack of awareness, denial, or fear of side effects. Treatments like finasteride, minoxidil (oral and topical), and hair transplants are discussed, with mixed results and concerns about side effects.
The user experienced hairloss and side effects from finasteride, switched to dutasteride and oral minoxidil, and saw improvements in beard and body hair but continued hairloss on the head. They plan to continue treatment and consider a hair transplant to improve results.
Alfatradiol is discussed as a hairloss treatment with minimal side effects, but its effectiveness is debated, and it's not widely known or available outside Germany. Some users report side effects like gyno and ball ache, while others find it effective in stopping shedding and itching.
A person struggling with hairloss is using treatments like dutasteride, oral minoxidil, and has had a hair transplant but remains deeply unhappy. Others suggest alternative treatments, acceptance, and focusing on other life aspects, emphasizing mental health and therapy.
An 18-year-old experiencing aggressive hairloss has been using 1mg finasteride and 2.5mg oral minoxidil for 162 days but continues to shed hair. Suggestions include switching to dutasteride, considering topical minoxidil, and consulting a dermatologist for further evaluation.
The conversation discusses hairloss treatments, focusing on a new slow-release oral minoxidil compared to topical minoxidil and finasteride. The results show that twice-daily dosing of the new treatment is slightly more effective than once-daily, but concerns about cost, side effects, and the accuracy of reported results remain.
Finasteride is used for hairloss, with mixed reports of no side effects and claims of long-term negative effects known as Post Finasteride Syndrome (PFS). The conversation debates the existence and causes of PFS, with differing opinions on whether it is psychological or real.
Young men experiencing hairloss are frustrated with advice to embrace baldness without exploring treatments. They advocate for using finasteride and minoxidil, considering hair transplants, and hope for future advancements in hair restoration.
The user is experiencing hairloss despite using dutasteride, minoxidil, and ketoconazole shampoo, and is concerned about continued shedding. Suggestions include checking for nutrient deficiencies, consulting a dermatologist, and considering other potential causes like seborrheic dermatitis or telogen effluvium.
Finasteride is a controversial hairloss treatment, with some users experiencing positive results and others facing side effects like erectile dysfunction. The discussion emphasizes the importance of personal choice and informed decision-making.
Red light therapy for hairloss is controversial, with mixed results reported. Its effectiveness may depend on device quality and proper wavelength, and it is often used with minoxidil and finasteride.
A new hairloss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.
A 37-year-old man is seeking advice for hairloss treatment, considering options like finasteride and topical or oral minoxidil. A user suggests consulting a doctor and monitoring blood pressure if using oral minoxidil.
The user experienced hairloss due to inconsistent oral minoxidil use while continuing dutasteride and topical minoxidil. Consistent treatment is advised for potential recovery of lost hair.
Stopping finasteride often leads to rapid hairloss, returning to a genetic baseline, as the drug temporarily halts hairloss and promotes regrowth. The discussion explores the complexity of hairloss, suggesting that factors beyond DHT, such as genetics and scalp conditions, may play a role.
PP405 is a potential hairloss treatment that may activate dormant hair follicles, but there are concerns about its effectiveness, cost, and side effects. Users discuss treatments like minoxidil, finasteride, and RU58841, expressing skepticism about PP405's long-term success and accessibility.
A user shared their 16-year hairloss journey using finasteride and minoxidil, noting slow hair thinning despite a family history of severe balding. They switched from topical to oral minoxidil but stopped for personal reasons, experiencing no significant side effects from finasteride.
PP405 is a promising hairloss treatment that may outperform minoxidil and finasteride by reviving dormant follicles and promoting significant regrowth. Results from ongoing trials are awaited, with a potential market release between 2028-2030.